List of Figures:
Figure 1. Research Method Flow Chart 11
Figure 2. Bottom-up Approach and Top-down Approach for Market Estimation 14
Figure 3. Europe Market Forecast in Optimistic, Conservative and Balanced Perspectives, 2019-2030 16
Figure 4. Europe Genome Sequencing Market, 2019-2030, $ mn 19
Figure 5. Impact of COVID-19 on Business 23
Figure 6. Primary Drivers and Impact Factors of Europe Genome Sequencing Market 25
Figure 7. World Number of Deaths by Cause in 2017 28
Figure 8. World Number of Deaths from Cancers in 2017 29
Figure 9. Worldwide Geriatric Population (60 years and above) by Regions, 2015 & 2030, million 30
Figure 10. World Population 65 and Over, % of Total Population, 1950-2060 30
Figure 11. Primary Restraints and Impact Factors of Europe Genome Sequencing Market 32
Figure 12. Investment Opportunity Analysis 36
Figure 13. Porter’s Fiver Forces Analysis of Europe Genome Sequencing Market 39
Figure 14. Breakdown of Europe Genome Sequencing Market by Product, 2019-2030, % of Revenue 44
Figure 15. Europe Addressable Market Cap in 2021-2030 by Product, Value ($ mn) and Share (%) 44
Figure 16. Europe Genome Sequencing Market by Product: Consumables, 2019-2030, $ mn 45
Figure 17. Europe Genome Sequencing Market by Product: Sequencers & Software, 2019-2030, $ mn 46
Figure 18. Europe Genome Sequencing Market by Product: Service, 2019-2030, $ mn 47
Figure 19. Breakdown of Europe Genome Sequencing Market by Technology, 2019-2030, % of Sales Revenue 49
Figure 20. Europe Addressable Market Cap in 2021-2030 by Technology, Value ($ mn) and Share (%) 49
Figure 21. Europe Genome Sequencing Market by Technology: Polymerase Chain Reaction (PCR), 2019-2030, $ mn 50
Figure 22. Europe Genome Sequencing Market by Technology: Sequencing, 2019-2030, $ mn 51
Figure 23. Europe Genome Sequencing Market by Technology: Microarray, 2019-2030, $ mn 52
Figure 24. Europe Genome Sequencing Market by Technology: Nucleic Acid Extraction and Purification, 2019-2030, $ mn 53
Figure 25. Europe Genome Sequencing Market by Technology: Other Technologies, 2019-2030, $ mn 54
Figure 26. Breakdown of Europe Genome Sequencing Market by Application, 2019-2030, % of Sales Revenue 56
Figure 27. Europe Addressable Market Cap in 2021-2030 by Application, Value ($ mn) and Share (%) 56
Figure 28. Europe Genome Sequencing Market by Application: Diagnostics, 2019-2030, $ mn 57
Figure 29. Europe Genome Sequencing Market by Diagnostics: Oncology, 2019-2030, $ mn 59
Figure 30. Europe Genome Sequencing Market by Diagnostics: Reproductive Health, 2019-2030, $ mn 60
Figure 31. Europe Genome Sequencing Market by Diagnostics: Complex Disease Research, 2019-2030, $ mn 61
Figure 32. Europe Genome Sequencing Market by Diagnostics: Other Diagnostics, 2019-2030, $ mn 62
Figure 33. Europe Genome Sequencing Market by Application: Drug Discovery and Development, 2019-2030, $ mn 63
Figure 34. Europe Genome Sequencing Market by Application: Precision Medicine, 2019-2030, $ mn 64
Figure 35. Europe Genome Sequencing Market by Application: Agriculture and Animal Research, 2019-2030, $ mn 65
Figure 36. Europe Genome Sequencing Market by Application: Other Applications, 2019-2030, $ mn 66
Figure 37. Breakdown of Europe Genome Sequencing Market by End User, 2019-2030, % of Revenue 68
Figure 38. Europe Addressable Market Cap in 2021-2030 by End User, Value ($ mn) and Share (%) 68
Figure 39. Europe Genome Sequencing Market by End User: Academic & Research Centers, 2019-2030, $ mn 69
Figure 40. Europe Genome Sequencing Market by End User: Pharmaceutical and Biotechnology Companies, 2019-2030, $ mn 70
Figure 41. Europe Genome Sequencing Market by End User: Consumer Genomic Service Providers, 2019-2030, $ mn 71
Figure 42. Europe Genome Sequencing Market by End User: Government Institutes, 2019-2030, $ mn 72
Figure 43. Europe Genome Sequencing Market by End User: Other End Users, 2019-2030, $ mn 73
Figure 44. Breakdown of European Genome Sequencing Market by Country, 2019 and 2030, % of Revenue 75
Figure 45. Contribution to Europe 2021-2030 Cumulative Market by Country, Value ($ mn) and Share (%) 76
Figure 46. Genome Sequencing Market in Germany, 2019-2030, $ mn 77
Figure 47. Genome Sequencing Market in U.K., 2019-2030, $ mn 79
Figure 48. Genome Sequencing Market in France, 2019-2030, $ mn 82
Figure 49. Genome Sequencing Market in Spain, 2019-2030, $ mn 84
Figure 50. Genome Sequencing Market in Italy, 2019-2030, $ mn 86
Figure 51. Genome Sequencing Market in Russia, 2019-2030, $ mn 88
Figure 52. Genome Sequencing Market in Rest of Europe, 2019-2030, $ mn 90
Figure 53. Growth Stage of Europe Genome Sequencing Industry over the Forecast Period 92
Europe genome sequencing market was valued at $1,955.5 million in 2020 and will grow by 12.3% annually over 2020-2030 owing to the growing government funding to encourage genomics projects, the increasing of the incidence of the cancer and the increasing applications of next-generation sequencing, and the utilization of genomics in specialized or personalized medicine. Highlighted with 33 tables and 53 figures, this 111-page report “Europe Genome Sequencing Market 2020-2030 by Product (Consumables, Sequencers & Software, Service), Technology (PCR, Sequencing, Microarray), Application, End User, and Country: Trend Forecast and Growth Opportunity” is based on a comprehensive research of the entire Europe genome sequencing market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2017-2019 and provides estimate for 2020 and forecast from 2021 till 2030 with 2019 as the base year (Year 2020 is not appropriate for research base due to the outbreak of COVID-19). In-depth qualitative analyses include identification and investigation of the following aspects: • Market Structure • Growth Drivers • Restraints and Challenges • Emerging Product Trends & Market Opportunities • Porter’s Fiver Forces The trend and outlook of Europe market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19. The balanced (most likely) projection is used to quantify Europe genome sequencing market in every aspect of the classification from perspectives of Product, Technology, Application, End User, and Country. Based on Product, the Europe market is segmented into the following sub-markets with annual revenue ($ mn) for 2019-2030 included in each section. • Consumables • Sequencers & Software • Service Based on Technology, the Europe market is segmented into the following sub-markets with annual revenue ($ mn) for 2019-2030 included in each section. • Polymerase Chain Reaction (PCR) • Sequencing • Microarray • Nucleic Acid Extraction and Purification • Other Technologies Based on Application, the Europe market is segmented into the following sub-markets with annual revenue ($ mn) for 2019-2030 included in each section. • Diagnostics • Oncology • Reproductive Health • Complex Disease Research • Other Diagnostics • Drug Discovery and Development • Precision Medicine • Agriculture and Animal Research • Other Applications By End User, the Europe market is segmented into the following sub-markets with annual revenue ($ mn) for 2019-2030 included in each section. • Academic & Research Centers • Pharmaceutical and Biotechnology Companies • Consumer Genomic Service Providers • Government Institutes • Other End Users Geographically, the following national/local markets are fully investigated: • Germany • UK • France • Spain • Italy • Russia • Rest of Europe (further segmented into Netherlands, Switzerland, Poland, Sweden, Belgium, Austria, Ireland, Norway, Denmark, and Finland) For each key country, detailed analysis and data for annual revenue ($ mn) are available for 2019-2030. The breakdown of key national markets by Product, Application, and End User over the forecast years are also included. The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players. Key Players (this may not be a complete list and extra companies can be added upon request): BGI Biomatters Bio-Rad Laboratories, Inc. DNASTAR F. Hoffmann-La Roche Illumina, Inc. Macrogen Inc. Myriad Genetics, Inc. New England Biolabs Oxford Nanopore Technology PerkinElmer Inc. Qiagen Siemens Healthineers Thermo Fisher Scientific (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)
Read More